Endoscopic proximal intestinal exclusion can improve non-alcoholic fatty liver disease (NAFLD) in patients with diabesity.

Presented by: B Hayee

Authors:

Hayee B, Sen Gupta P, Anderson M, Fogden E, Roy AA, Butler DB, Bajwa RS, Amiel SA, Ryder REJ.

Endoscopic proximal intestinal exclusion with Endobarrier bringing simultaneous benefit to both diabesity and obstructive sleep apnoea(OSA) requiring overnight continuous positive airway pressure ventilation(CPAP)- Case reports

Authors:

M Yadagiri, MH Lang, AAS Mohammed, N Nathani, AB Rajasekharan, JP Bleasdale, EN Fogden, MR Anderson, P Sen Gupta, REJ Ryder.

A reminder to ABCD members that voting closes soon (3 April, midday) for the Royal College of Physicians elected councillors.

Two diabetologists are standing for election:

The interaction of endoscopic proximal intestinal exclusion therapy using Endobarrier with GLP-1 therapy rapidly improves type 2 diabetes by increasing fasting and postprandial satiety.

Authors:

P Sen Gupta, RS Drummond, BM McGowan, B Hayee, T Dew, RP Vincent, CW le Roux, JJ Holst, SA Amiel, REJ Ryder

Institution of the UK’s first National Health Service Endobarrier service for type 2 diabetes and obesity.

Authors:

P Sen Gupta, M Yadagiri, SP Irwin, W Burbridge, H Gandhi, RA Allden, JP Bleasdale, EN Fogden, M Anderson and REJ Ryder

UK first NHS Endobarrier service for diabesity: outcomes in the first 30 patients to reach six months after explanation of the device.

Authors:

REJ Ryder, M Yadagiri, SP Irwin, W Burbridge, H Gandhi, RA Allden, JP Bleasdale, EN Fogden, M Anderson and P Sen Gupta

Cost-Effectiveness Analysis of the EndoBarrier Device in Patients with Type 2 Diabetes and Obesity.

Authors:

S Armstrong, P Sen Gupta, SA Amiel, RS Drummond, BM McGowan, REJ Ryder, MW Pennington

Preliminary results of the Association of British Clinical Diabetologists sponsored Endobarrier in type 2 diabetes/pre-diabetes with obstructive sleep apnoea study.

Authors:

M Yadagiri, N Ashman, F Kinney, M Lang, JP Bleasdale, EN Fogden, MR Anderson, M Greenstone, C Walton, REJ Ryder

UK first NHS EndoBarrier service for advanced type 2 diabetes and obesity: one year outcomes in all patients treated.

Authors:

REJ Ryder, M Yadagiri, SP Irwin, W Burbridge, T Bashir, RA Allden, JP Bleasdale, EN Fogden, M Anderson and P Sen Gupta.

One year results of the Association of British Clinical Diabetologists (ABCD) sponsored Endobarrier in type 2 diabetes/pre-diabetes with Obstructive sleep apnoea(OSA) study

Authors:

M Yadagiri, F Kinney, J Adams, A Mohammed, JP Bleasdale, EN Fogden, MR Anderson, M Greenstone, C Walton, REJ Ryder